Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
Molecular Metabolism|December 23, 2018
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonismPiotr A Mroz, Brian Finan, Vasily Gelfanov, et al.Molecular Metabolism|October 17, 2017
Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartmentShravan Babu Girada, Ramya S Kuna, Shilpak Bele, et al.Diabetologia|July 23, 2017
GLP-1/glucagon receptor co-agonism for treatment of obesityMiguel A Sánchez-Garrido, Sara J Brandt, Christoffer Clemmensen, et al.Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.Cell|July 26, 2024
Transforming obesity: The advancement of multi-receptor drugsChristine M Kusminski, Diego Perez-Tilve, Timo D Müller, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|April 12, 2012
Site-specific fluorescein labeling of human insulinFa Liu, Wayne D Kohn, John P MayerJournal of Peptide Science : an Official Publication of the European Peptide Society|February 11, 2011
Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone actionJonathan W Day, Pengyun Li, James T Patterson, et al.Frontiers in Endocrinology|March 18, 2022
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and DiabetesQiming Tan, Seun E Akindehin, Camila E Orsso, et al.Molecular Metabolism|March 4, 2026
Discovery and Characterization of Canvuparatide, a Once-Weekly Parathyroid Hormone Analog for the Treatment of HypoparathyroidismFa Zhang, Diego Perez-Tilve, Matthew R Allen, et al.Chembiochem : a European Journal of Chemical Biology|December 31, 2019
Stepwise Construction of Disulfides in PeptidesRongjun He, Jia Pan, John P Mayer, et al.Pageof 14